WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002083704) VASCULAR ENDOTHELIAL GROWTH FACTOR 2
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/083704    International Application No.:    PCT/US2002/011474
Publication Date: 24.10.2002 International Filing Date: 12.04.2002
Chapter 2 Demand Filed:    07.11.2002    
IPC:
A61K 38/00 (2006.01), A61K 48/00 (2006.01), C07K 14/52 (2006.01), C07K 16/24 (2006.01)
Applicants: HUMAN GENOME SCIENCES, INC. [US/US]; 9410 Key West Avenue, Rockville, MD 20850 (US) (For All Designated States Except US).
ROSEN, Craig, A. [US/US]; (US) (For US Only).
ALBERT, Vivian, R. [US/US]; (US) (For US Only).
RUBEN, Steven, M. [US/US]; (US) (For US Only).
WAGER, Ruth, E. [US/US]; (US) (For US Only)
Inventors: ROSEN, Craig, A.; (US).
ALBERT, Vivian, R.; (US).
RUBEN, Steven, M.; (US).
WAGER, Ruth, E.; (US)
Agent: WALES, Michele, M.; Human Genome Sciences, Inc., 9410 Key West Avenue, Rockville, MD 20850 (US)
Priority Data:
60/283,385 13.04.2001 US
60/350,366 24.01.2002 US
Title (EN) VASCULAR ENDOTHELIAL GROWTH FACTOR 2
(FR) FACTEUR DE CROISSANCE 2, ENDOTHELIAL, VASCULAIRE
Abstract: front page image
(EN)Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
(FR)L'invention concerne des anticorps VEGF-2 humains, des fragments d'anticorps ou des variants correspondants, ainsi que des processus de production de ces anticorps. La présente invention a également trait à des méthodes et à des compositions servant à prévenir, traiter ou améliorer une maladie ou un trouble. Lesdites méthodes consistent à administrer à un animal, de préférence, à un être humain, une quantité efficace d'au moins un anticorps VEGF-2 ou des fragments ou des variants correspondants.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)